Internal Medicine, Pulmonary Disease · Millville, NJ
NPI
1144474636
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1306 High St N
Millville, NJ, 08332
Phone (856) 875-3630
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
3,741 services
Medicare patients, 2024
694
Average age 73
Drug cost, 2024
$2.7M
3,806 prescriptions
Company payments, 2025
$238K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manuel S Cunanan was code 99214 (office e&m - established), 770 times for 438 patients. In total Manuel S Cunanan billed 3,741 services in 22 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 770 | 438 | $98.44 | $76K |
| 94618 Pulmonary Function Testing | Office | 532 | 450 | $29.16 | $16K |
| 94727 Pulmonary Function Testing | Office | 516 | 439 | $39.52 | $20K |
| 94729 Pulmonary Function Testing | Office | 516 | 439 | $50.94 | $26K |
| 94060 Pulmonary Function Testing | Office | 504 | 432 | $33.75 | $17K |
| 99213 Office E&M - Established | Office | 393 | 300 | $66.37 | $26K |
| 99204 Office E&M - New | Office | 192 | 192 | $135.19 | $26K |
| 96372 Injection Administration | Office | 94 | 22 | $11.47 | $1,078 |
| G0398 Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 39 | 39 | $77.42 | $3,020 |
| 99406 Behavioral Health Services | Office | 30 | 26 | $15.97 | $479 |
| 94664 E&M - Miscellaneous | Office | 24 | 24 | $16.33 | $392 |
| 99215 Office E&M - Established | Office | 21 | 20 | $158.14 | $3,321 |
| 99407 Behavioral Health Services | Office | 17 | 17 | $29.70 | $505 |
| 95800 Sleep Study | Office | 16 | 16 | $115.53 | $1,849 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 12 | 12 | $56.15 | $674 |
By year: 2022 $219K for 3,404 services; 2023 $282K for 4,542 services; 2024 $221K for 3,741 services.
Medicare prescription drug claims, 2024
In 2024, the drug Manuel S Cunanan prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 429 prescriptions and refills. In total Manuel S Cunanan wrote 3,806 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 429 | 460 | 139 | $12K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 399 | 532 | 135 | $322K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 366 | 487 | 108 | $305K |
| Montelukast Sodium Generic | 257 | 393 | 81 | $2,164 |
| Prednisone Generic | 194 | 233 | 90 | $691 |
| Levocetirizine Dihydrochloride Generic | 187 | 263 | 51 | $2,898 |
| Incruse Ellipta Umeclidinium Bromide | 170 | 186 | 46 | $63K |
| Spiriva Respimat Tiotropium Bromide | 170 | 222 | 53 | $115K |
| Fluticasone Propionate Generic | 158 | 280 | 77 | $3,091 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 150 | 174 | 49 | $19K |
| Breo Ellipta Fluticasone/Vilanterol | 108 | 132 | 34 | $52K |
| Tezspire Tezepelumab-Ekko | 86 | 86 | 17 | $372K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 83 | 111 | 31 | $19K |
| Ventolin Hfa Albuterol Sulfate | 82 | 88 | 33 | $4,851 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 80 | 103 | 26 | $23K |
Brand drugs: 2,453 claims; generic drugs: 1,353 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manuel S Cunanan $238K ($238K in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $161K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 188 | $161K |
| Genzyme Corporation SNY | 35 | $31K |
| Regeneron Healthcare Solutions, Inc. REGN | 37 | $18K |
| Verona Pharma, Inc. VRNA | 34 | $17K |
| Grifols USA, LLC | 12 | $4,711 |
| Optinose US, Inc. | 9 | $3,846 |
| ANI Pharmaceuticals, Inc. ANIP | 24 | $569 |
| GlaxoSmithKline, LLC. GSK | 31 | $465 |
| Mallinckrodt Hospital Products Inc. | 13 | $296 |
| Amgen Inc. AMGN | 16 | $210 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.